Market Research Logo

The World Market for Pain Management Drugs and Devices

The World Market for Pain Management Drugs and Devices encompasses a wide variety of products that treat and ease pain. The field of pain management is currently experiencing a busy and interesting period; and as a result, the range of therapeutic options available to physicians and other clinicians has expanded. Solutions to pain disorders are still elusive but continued human and animal studies will help to further identify the biochemical and neurophysiological factors that influence pain. The future of pain management will likely involve multidisciplinary departments dedicated to finding treatments that manage pain. The need is great worldwide for management of pain and there are still many facets of pain management that need to be explored.

Faced with intensifying competition and increasingly price sensitive markets, manufacturers in the area of pain management therapeutics are trying to differentiate their products to avoid price competition and to increase profits. However, there are a number of issues and trends that have a direct influence on this market and the manufacturer’s ability to successfully operate in the market. A keen awareness of all facets of the industry including barriers will enable manufacturers to effectively challenge these issues and formulate plans to reduce or eliminate barriers in the treatment of pain.

The driving forces for this market include growth and aging of the global population, new products and technology, and increasing interest in multidisciplinary approaches to pain management.

This report, The World Market for Pain Management Drugs and Devices, provides market estimates and forecasts for the following therapeutic categories:

  • Burn Pain
  • Cancer Pain
  • Dental/Facial Pain
  • Migraine Headache Pain
  • Musculoskeletal Pain
  • Neuropathic Pain
  • Obstetrical Pain
  • Pediatric Pain
  • Surgical and Trauma Pain
This report details the various categories of top prescription pain management drugs, describes U.S., European, Japanese and other markets in each of the specific pain areas. The report also covers drug delivery methods, pain management devices, and alternate treatment modalities that are influencing the market. It further identifies major market factors, which are discussed, and a total market summary is presented.

The information and analysis presented in this report are based on extensive interviews with senior management of top companies and conference participants (business and clinical) in the pain management market. Background information was obtained from a comprehensive search of published literature and reports obtained from various government, business, medical trade, and international journals. Key information from published literature was used to conduct interviews with over 45 industry executives and product managers to validate and obtain expert opinion on current and future trends in the pain management market. Interviews were also used to confirm and/or adjust market size estimates, as well as in formulating market projections.

All market data pertain to the world market at the manufacturers’ level. Data are expressed in current U.S. dollars. The base year for data was 2012. Historical data is provided for 2010 and 2011, and forecast data are provided for each of the years 2012 through 2017. Historical, base year, and forecast data are provided for each market segment. Market shares are provided for each market segment for the 2012 base year.

Top product revenues are considered for the report in each subsegment according to treatment use. Top products in each category represent approximately 80% of the total revenues for each subsegment. The total market reflects the total revenues of all top products in all of the individual categories, representing approximately 80%-90% of the total prescription pain management pharmaceuticals and pain management devices.

As part of the study the following competitors are profiled:
  • Abbott Laboratories
  • Actavis, Inc (formerly Watson Pharmaceuticals, Inc.)
  • AstraZeneca plc.
  • Baxter International, Inc.
  • BioDelivery Sciences International (BDSI)
  • Boehringer Ingelheim
  • Boston Scientific
  • Bristol-Myers Squibb Company
  • DepoMed
  • DURECT Corporation
  • Eli Lilly & Co.
  • Endo Health Solutions Inc
  • GlaxoSmithKline plc
  • Grunenthal Group
  • Medtronic, Inc.
  • Merck & Co.
  • Novartis
  • Pain Therapeutics, Inc
  • Pfizer, Inc
  • Purdue Pharma
  • QRx Pharma
  • Sanofi
  • St. Jude Medical, Inc
  • TEVA Pharmaceuticals Industries, Ltd
  • The Medicines Company
  • Valeant Pharmaceuticals International, Inc.
  • Zogenix, Inc.


  • Executive Summary
    • INTRODUCTION
    • SCOPE AND METHODOLOGY
    • SIZE AND GROWTH OF THE MARKET
      • Table Total World Pain Management Market 2010-2017
    • ISSUES AND TRENDS
    • LEADING COMPETITORS
  • Introduction and Overview
    • DEFINITION OF PAIN
    • MAGNITUDE OF PAIN
    • PHYSIOLOGY OF PAIN
      • Transduction
      • Transmission
    • PAIN PATHWAYS
    • TYPES OF PAIN
    • MEASUREMENT OF PAIN
      • Table Most Commonly Used Pain Quality Descriptors
    • TREATMENT MODALITIES-PHARMACOLOGIC MANAGEMENT
      • Analgesic Ladder
        • Table Pharmacokinetics of Step I Analgesics by Product
        • Table Step II Analgesics: Pharmacokinetics
        • Table Step III Analgesics: Pharmacokinetics
      • Recommended Drug and Route
    • TREATMENT MODALITIES-NON-PHARMACOLOGIC MANAGEMENT
      • Cognitive-Behavioral Therapies
      • Multidisciplinary Pain Management
      • Demographics
        • Table Worldwide Prevalence of Selected Pain Related Conditions (est.2012)
  • Treatment Markets and Forecasts
    • BURN PAIN
      • Overview of Top Products
      • Market Size and Growth
        • Table World Market for Burn Pain Market 2010-2017
      • Markets by Region
        • Table Regional Markets for Burn Pain Management 20010-2017
    • CANCER PAIN
      • Breakthrough Cancer Pain
      • Overview of Top Products
      • Market Size and Growth
        • Table World Market for Cancer Pain Management 2010-2017
      • Markets by Region
        • Table Regional Markets for Cancer Pain Management 2010-2017
    • DENTAL/FACIAL PAIN
      • Overview of Top Products
      • Market Size and Growth
        • Table The World Market for Dental/Facial Pain Management 2010-2017
      • Markets by Region
        • Table Regional Markets for Dental/Facial Pain Management 2010-2017
    • MIGRAINE HEADACHE PAIN
      • Overview of Top Products
      • Market Size and Growth
        • Table World Market for Migraine Pain Management 2010-2017
      • Markets by Region
        • Table Regional Markets for Migraine Pain Management 2010-2017
    • MUSCULOSKELETAL PAIN
      • Overview of Top Products
      • Market Size and Growth
        • Table World Market for Musculoskeletal Pain Management 2010-2017
      • Markets by Region
        • Table Regional Markets for Musculoskeletal Pain Management 2010-2017
    • NEUROPATHIC PAIN
      • Overview of Top Products
      • Market Size and Growth
        • Table World Market for Neuropathic Pain Management 2010-2017
      • Markets by Region
        • Table Regional Markets for Neuropathic Pain Management 2010-2017
    • OBSTETRICAL PAIN
      • Overview of Top Products
      • Market Size and Growth
        • Table World Market for Obstetrical Pain Management 2010-2017
      • Markets by Region
        • Table Regional Markets for Obstetrical Pain Management 2010-2017
    • PEDIATRIC PAIN
      • Overview of Top Products
      • Market Size and Growth
        • Table The World Market for Pediatric Pain Management 2010-2017
      • Markets by Region
        • Table Regional Markets for Pediatric Pain Management 2010-2017
    • SURGICAL AND TRAUMA PAIN
      • Overview of Top Products
      • Market Size and Growth
        • Table World Market for Surgical and Trauma Pain Management 2010-2017
      • Markets by Region
        • Table Regional Markets for Surgical and Trauma Pain Management 2010-2017
  • Drug Delivery
    • ORAL DRUG DELIVERY
    • PARENTERAL DRUG DELIVERY
    • TRANSDERMAL
    • PATIENT CONTROLLED ANALGESIA
    • INTRATHECAL IMPLANTS
    • ELECTROTRANSPORT DRUG DELIVERY
  • Pain Management Devices
    • TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS
    • NEUROMUSCULAR STIMULATORS
    • SPINAL CORD STIMULATORS AND PERIPHERAL NERVE STIMULATORS
    • PCAS AND INTRATHECAL PAIN PUMPS
    • OTHERMISCELLANEOUS DEVICES
      • Cranial Electrotherapy Stimulation
      • Electrothermal and Electromagnetic Therapy
      • Thermography
    • MARKET SIZE AND GROWTH
      • Table World Market for Pain Management Devices 2010-2017
      • Markets by Region
        • Table Regional Markets for Pain Management Devices 2010-2017
  • Alternate Treatment Modalities
    • ACUPUNCTURE
    • ETPS NEUROPATHIC ACUPUNCTURE
    • LOW LEVEL LASER LIGHT THERAPY
    • BIOFEEDBACK
    • RELAXATION
    • MUSIC AND PAIN RELIEF
    • WAVE THERAPY
    • ACUPRESSURE
    • MASSAGE THERAPY
    • NATURAL SUPPLEMENTS IN PAINMANAGEMENT
      • Table Pain Management Supplements in Clinical Trials
    • BIOELECTROMAGNETISM
    • RADIOFREQUENCY TECHNOLOGY
    • CRYOABLATION
  • Issues and Trends
    • OVERVIEW
    • BARRIERS TO CANCER PAIN MANAGEMENT
    • EDUCATION
    • CHRONIC PAIN AND WORK
    • MANAGED CARE PAIN MANAGEMENT
    • THE FIFTH VITAL SIGN
    • USE OF PSYCHOPHARMACOLOGY IN CHRONIC PAIN
    • USE OF BOTULINUM NEUROTOXIN
    • RESEARCH AND DEVELOPMENT
      • Dyloject
      • Levadex
      • MoxDuo IR
      • Naproxcinod
      • Pennsaid 2%
      • Posidur
      • Remoxy
      • Zelrix
      • Zohydro ER
      • ARC-4558
      • BEMA Buprenorphine
      • NGX 1998
      • Sativex
      • ATx08-001
        • Table Pain Management Products in Development 2012
    • THE ELDERLY
    • OXYCONTIN ISSUES
    • CONSTANT PAIN PHENOMENON
    • TYLENOL AND LIVER DAMAGE
    • PAINMEDICATION TREATMENT CONFUSION
    • TRANSPORTER DISCOVERY
    • MARIJUANA AND PAIN CONTROL
    • ABUSE-DETERRENT PAINKILLERS
    • DRUG ABUSE AND PAIN CONTROL
  • Market Summary
    • TOTAL MARKET SIZE AND FORECAST
      • Table Total World Pain Management Market 2010-2017
      • Table World Pain Management Market by Product Segment (Pain Type), 2010-2017
    • TOTAL MARKET REVENUES BY REGION
      • Table Total Regional Markets for Pain Management 2010-2017
    • COMPETITOR ANALYSIS
      • Table World Market for Top Pain Management Treatments Revenues and Segments of Participation by Major Areas of Participation 2012
      • Table Revenues and Market Share by Company 2012 (some are estimated)
  • Corporate Profiles
    • ABBOTT LABORATORIES
    • ACTAVIS, INC (FORMERLY WATSON PHARMACEUTICALS, INC.)
    • ASTRAZENECA PLC.
    • BAXTER INTERNATIONAL, INC.
    • BIODELIVERY SCIENCES INTERNATIONAL (BDSI)
    • BOEHRINGER INGELHEIM
    • BOSTON SCIENTIFIC
    • BRISTOL-MYERS SQUIBB COMPANY
    • DEPOMED
    • DURECT CORPORATION
    • ELI LILLY &CO.
    • ENDO HEALTH SOLUTIONS INC
    • GLAXOSMITHKLINE PLC
    • GRUNENTHAL GROUP
    • MEDTRONIC, INC.
    • MERCK&CO.
    • NOVARTIS
    • PAIN THERAPEUTICS, INC
    • PFIZER, INC
    • PURDUE PHARMA
    • QRX PHARMA
    • SANOFI
    • ST. JUDEMEDICAL, INC
    • TEVAPHARMACEUTICALS INDUSTRIES, LTD
    • THEMEDICINES COMPANY
    • VALEANT PHARMACEUTICALS INTERNATIONAL, INC.
    • ZOGENIX, INC.
  • Company Directory

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report